Delivery Order SPE2DR25D2009-SPE2DR26FJ3Y7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, with a ceiling value of $1,176.87 and a firm fixed price structure. The order is scheduled for completion by November 28, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and is issued under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,249.33 delivery order on December 2, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units, with completion scheduled for December 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,045.64 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count packaging) with an ultimate completion date of November 7, 2025. This non-competitive, firm fixed-price delivery order was issued on November 6, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $3,612.72 to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count supply) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a competitive delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Methylphenidate ER Tablets 18mg, a controlled-release formulation commonly used in the treatment of attention-deficit/hyperactivity disorder. This firm fixed-price delivery order, valued at $6,390.70, carries an ultimate completion date of November 6, 2025, and represents a non-set-aside procurement. The award was issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) valued at $2,634.43. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order valued at $7,779.01 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 20, 2025, issued on October 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count) with a contract value of $2,472.41. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was competitively awarded. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ3Y7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100s, with a ceiling value of $3,038.08 under a firm fixed-price arrangement. This delivery order represents a non-set-aside competitive award with an ultimate completion date of December 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under its larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle valued through December 2026. AmerisourceBergen Drug Corp serves as a critical vendor in the federal medical procurement supply chain, providing comprehensive pharmaceutical and medical supply solutions to military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive federal contract portfolio demonstrates its capability to deliver a wide range of therapeutic products, from generic medications to specialty pharmaceuticals, across multiple therapeutic domains. This particular delivery order for Methylphenidate ER, a controlled medication used to treat attention-deficit/hyperactivity disorder, exemplifies the company's role in supporting the military health system's pharmaceutical requirements through competitive, fixed-price procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 12/7/25 |